Abstract

Renal artery embolism was described first in year 1940, but recently it is recognized as a clinically significant entity. It is a rare event, mostly seen in patients of 60 to 80 years old, with certain predisposing risk factors for tromboembolism, dominantly with underlying cardiovascular disease including atrial fibrillation, rheumatic heart disease, cardiac heart failure, arterial hypertension and general atherosclerosis. Renal artery embolism causes asymptomatic to sudden onset of nonspecific symptoms such as fever, abdominal pain, vomiting and nausea. There are few treatment options for renal artery embolism and some of them are early anticoagulation therapy and trombolytic therapy with streptokinase or tissue plasminogen activator preferably in early stage 90-180 min from onset. Medicamentous can be choice as a first line of treatment is more favourable than surgical therapy that is preferred in patients with solitary kidney or bilateral emboli.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.